MaaT Pharma SA (EPA:MAAT)
France flag France · Delayed Price · Currency is EUR
4.240
-0.070 (-1.62%)
Oct 17, 2025, 5:35 PM CET

MaaT Pharma Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
681118179132-
Upgrade
Market Cap Growth
-33.23%36.57%2.32%-40.01%--
Upgrade
Enterprise Value
68975949123-
Upgrade
Last Close Price
4.247.966.988.0013.35-
Upgrade
PS Ratio
17.4134.3936.3555.35135.75-
Upgrade
PB Ratio
8.2310.703.962.953.31-
Upgrade
P/TBV Ratio
12.5512.914.243.093.38-
Upgrade
EV/Sales Ratio
17.2530.0526.4134.22126.09-
Upgrade
Debt / Equity Ratio
1.741.540.690.420.150.38
Upgrade
Asset Turnover
0.080.080.050.030.03-
Upgrade
Inventory Turnover
13.9312.717.4116.05--
Upgrade
Quick Ratio
2.151.812.654.389.937.75
Upgrade
Current Ratio
2.221.902.784.5710.057.76
Upgrade
Return on Equity (ROE)
-183.64%-187.68%-83.41%-41.14%-32.33%-92.67%
Upgrade
Return on Assets (ROA)
-38.10%-43.64%-28.44%-18.00%-15.08%-20.62%
Upgrade
Return on Capital (ROIC)
-58.07%-58.41%-34.28%-20.21%-16.43%-25.55%
Upgrade
Earnings Yield
-45.59%-26.13%-24.34%-17.32%-6.83%-
Upgrade
FCF Yield
-37.27%-20.61%-24.40%-16.76%-6.19%-
Upgrade
Buyback Yield / Dilution
-22.07%-14.95%-14.89%-307.65%-135.06%-
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.